Natera, INC Form 4 insider transactions

Michael Brophy, CFO of Natera, Inc., sold shares of common stock to satisfy tax withholding obligations related to the vesting of Restricted Stock Units (RSUs).

Director Herm Rosenman acquired 206 shares of Natera, Inc. common stock on July 26, 2024, through the issuance of fully vested RSUs in lieu of quarterly retainer fees.

Director James Healy acquired 177 shares of Natera, Inc. common stock in lieu of quarterly retainer fees.

Director Roelof Botha acquired 234 shares of Natera, Inc. common stock through the issuance of fully vested RSUs in lieu of quarterly retainer fees.

Director Roy D. Baynes acquired 143 shares of Natera, Inc. common stock through the issuance of fully vested Restricted Stock Units (RSUs) in lieu of quarterly retainer fees.

Natera's CFO, Michael Brophy, executed multiple sales of common stock between July 24 and July 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 549 shares of common stock on July 22, 2024, to satisfy tax withholding obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 549 shares of common stock on July 22, 2024, to cover tax obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Jonathan Sheena, co-founder of Natera, Inc., reports transactions involving restricted stock units and common stock.

Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc., reports transactions involving common stock and restricted stock units.

Natera's CEO, Steven Chapman, sold a portion of his common stock holdings on July 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., sold a portion of their common stock holdings on July 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Brinkley Ruth Williams acquired 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, which vest on June 12, 2025, or upon a change in control.

Director Rosenman Herm acquired 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, which vest on June 12, 2025.

Director Marcus Gail Boxer reported the acquisition of 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, according to a Form 4 filing.

Director James Healy reports the acquisition of 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024, vesting fully on June 12, 2025, with accelerated vesting upon a change in control.

Director Rowan E. Chapman reports acquisition of 2,964 restricted stock units (RSUs) of Natera, Inc. on June 28, 2024.

Director Roelof Botha reports acquisition of restricted stock units and transfer of shares to an estate planning vehicle.

Roy D. Baynes, a director at Natera, Inc., reported the acquisition of 2,964 restricted stock units (RSUs) on June 28, 2024.

Jonathan Sheena, co-founder of Natera, Inc., sold 2,700 shares of common stock at an average price of $109.6591 under a pre-arranged Rule 10b5-1 trading plan.

Natera's CEO, Steven Chapman, sold a portion of his common stock holdings under a pre-arranged Rule 10b5-1 trading plan.

Gail Boxer Marcus, a director at Natera, Inc., sold 2,000 shares of common stock at a price of $110.165 per share on May 30, 2024.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 1,647 shares of common stock on May 28, 2024, to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 1,438 shares of common stock on May 28, 2024, to cover tax obligations related to vesting RSUs.

Director Rowan E. Chapman of Natera, Inc. sold 4,856 shares of common stock at an average price of $109.0874 on May 28, 2024.